SWTX

SpringWorks Therapeutics, Inc. - common stock (SWTX)

About SpringWorks Therapeutics, Inc. - common stock (SWTX)

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.

Details

Daily high

$46.90

Daily low

$46.74

Price at open

52 Week High

$62.00

52 Week Low

$28.21

Market cap

3.5B

Dividend yield

0.00%

Volume

8.1M

Avg. volume

4.6M

P/E ratio

-13.72

SpringWorks Therapeutics, Inc. - common stock News